Da: Better World Books Ltd, Dunfermline, Regno Unito
EUR 5,75
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Good. 5th. Former library copy. Pages intact with minimal writing/highlighting. The binding may be loose and creased. Dust jackets/supplements are not included. Includes library markings. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.
Lingua: Inglese
Editore: Lippincott Williams and Wilkins, 1992
ISBN 10: 0397512643 ISBN 13: 9780397512645
Da: Ammareal, Morangis, Francia
EUR 3,14
Quantità: 1 disponibili
Aggiungi al carrelloSoftcover. Condizione: Bon. Traces d'usure sur la couverture. Edition 1992. Ammareal reverse jusqu'à 15% du prix net de cet article à des organisations caritatives. ENGLISH DESCRIPTION Book Condition: Used, Good. Signs of wear on the cover. Edition 1992. Ammareal gives back up to 15% of this item's net price to charity organizations.
Lingua: Inglese
Editore: Lippincott Williams & Wilkins, 1998
ISBN 10: 0781716926 ISBN 13: 9780781716925
Da: HPB-Red, Dallas, TX, U.S.A.
CD-ROM. Condizione: Good. Connecting readers with great books since 1972! Used textbooks may not include companion materials such as access codes, etc. May have some wear or writing/highlighting. We ship orders daily and Customer Service is our top priority!
Da: Universitätsbuchhandlung Herta Hold GmbH, Berlin, Germania
EUR 11,00
Quantità: 2 disponibili
Aggiungi al carrello5th ed. 505 ills., XV, 383 p. Softcover. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. 5th edition. Stamped. Sprache: Englisch.
Da: Wissenschaftl. Antiquariat Th. Haker e.K, Klettgau, Germania
EUR 15,80
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Sehr gut. 308 p. In very good condition. ISBN: 9783540586883 Sprache: Englisch Gewicht in Gramm: 383 15,5 x 1,8 x 23,5 cm, softcover.
Lingua: Inglese
Editore: Lippincott Williams & Wilkins, 1992
ISBN 10: 0397512643 ISBN 13: 9780397512645
Da: Basi6 International, Irving, TX, U.S.A.
Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Lingua: Inglese
Editore: Lippincott Williams & Wilkins, 1992
ISBN 10: 0397512643 ISBN 13: 9780397512645
Da: Romtrade Corp., STERLING HEIGHTS, MI, U.S.A.
Condizione: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Condizione: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
Lingua: Inglese
Editore: Berlin ; Heidelberg ; New York ; Barcelona ; Budapest ; Hong Kong ; London ; Milan ; Paris ; Tokyo : Springer, 1995
ISBN 10: 3540586881 ISBN 13: 9783540586883
Da: Roland Antiquariat UG haftungsbeschränkt, Weinheim, Germania
EUR 40,00
Quantità: 1 disponibili
Aggiungi al carrelloSoftcover/Paperback. XVI, 290 p.; 14 fig., 60 tabs. Good condition. Reading pages are clean and without markings. Retired library exemplar, with the usual marking. Book shows slight signs of storage and usage. Otherwise good copy. 9783540586883 Sprache: Englisch Gewicht in Gramm: 520.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 113,71
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
EUR 150,86
Quantità: 2 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. 1st edition. 290 pages. 9.50x6.25x0.75 inches. In Stock.
EUR 95,70
Quantità: 5 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Prognostic Factors in Cancer | Paul Hermanek (u. a.) | Taschenbuch | Einband - flex.(Paperback) | Englisch | 1995 | Springer-Verlag GmbH | EAN 9783540586883 | Verantwortliche Person für die EU: Springer Heidelberg, Tiergartenstr. 17, 69121 Heidelberg, buchhandel-buch[at]springer[dot]com | Anbieter: preigu.
Lingua: Inglese
Editore: Springer Berlin Heidelberg, 1995
ISBN 10: 3540586881 ISBN 13: 9783540586883
Da: moluna, Greven, Germania
EUR 118,64
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. M. K. Gospodarowicz, P. Hermanek, and D. E. Henson Attention to innovations in cancer treatment has tended to eclipse the importance of prognostic assessment. However, the recognition that prognostic factors often have a greater impact on outcome than avail.
Lingua: Inglese
Editore: Springer Berlin Heidelberg, Springer Berlin Heidelberg, 1995
ISBN 10: 3540586881 ISBN 13: 9783540586883
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 106,99
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - M. K. Gospodarowicz, P. Hermanek, and D. E. Henson Attention to innovations in cancer treatment has tended to eclipse the importance of prognostic assessment. However, the recognition that prognostic factors often have a greater impact on outcome than available therapies and the proliferation of biochemical, molecular, and genetic markers have resulted in renewed interest in this field. The outcome in patients with cancer is determined by a combination of numerous factors. Presently, the most widely recognized are the extent of disease, histologic type of tumor, and treatment. It has been known for some time that additional factors also influence outcome. These include histologic grade, lymphatic or vascular invasion, mitotic index, performance status, symptoms, and most recently genetic and biochemical markers. It is the aim of this volume to compile those prognostic factors that have emerged as important determinants of outcome for tumors at various sites. This compilation represents the first phase of a more extensive process to integrate all prognostic factors in cancer to further enhance the prediction of outcome following treatment. Certain issues surround ing the assessment and reporting of prognostic factors are also considered. Importance of Prognostic Factors Prognostic factors in cancer often have an immense influence on outcome, while treatment often has a much weaker effect. For example, the influence of the presence of lymph node involvement on survival of patients with metastatic breast cancer is much greater than the effect of adjuvant treatment with tamoxifen in the same group of patients [5].
Lingua: Inglese
Editore: Springer Berlin Heidelberg Jul 1995, 1995
ISBN 10: 3540586881 ISBN 13: 9783540586883
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
EUR 106,99
Quantità: 2 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -M. K. Gospodarowicz, P. Hermanek, and D. E. Henson Attention to innovations in cancer treatment has tended to eclipse the importance of prognostic assessment. However, the recognition that prognostic factors often have a greater impact on outcome than available therapies and the proliferation of biochemical, molecular, and genetic markers have resulted in renewed interest in this field. The outcome in patients with cancer is determined by a combination of numerous factors. Presently, the most widely recognized are the extent of disease, histologic type of tumor, and treatment. It has been known for some time that additional factors also influence outcome. These include histologic grade, lymphatic or vascular invasion, mitotic index, performance status, symptoms, and most recently genetic and biochemical markers. It is the aim of this volume to compile those prognostic factors that have emerged as important determinants of outcome for tumors at various sites. This compilation represents the first phase of a more extensive process to integrate all prognostic factors in cancer to further enhance the prediction of outcome following treatment. Certain issues surround ing the assessment and reporting of prognostic factors are also considered. Importance of Prognostic Factors Prognostic factors in cancer often have an immense influence on outcome, while treatment often has a much weaker effect. For example, the influence of the presence of lymph node involvement on survival of patients with metastatic breast cancer is much greater than the effect of adjuvant treatment with tamoxifen in the same group of patients [5]. 308 pp. Englisch.
Lingua: Inglese
Editore: Springer Berlin Heidelberg, Springer Berlin Heidelberg Jul 1995, 1995
ISBN 10: 3540586881 ISBN 13: 9783540586883
Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germania
EUR 106,99
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -M. K. Gospodarowicz, P. Hermanek, and D. E. Henson Attention to innovations in cancer treatment has tended to eclipse the importance of prognostic assessment. However, the recognition that prognostic factors often have a greater impact on outcome than available therapies and the proliferation of biochemical, molecular, and genetic markers have resulted in renewed interest in this field. The outcome in patients with cancer is determined by a combination of numerous factors. Presently, the most widely recognized are the extent of disease, histologic type of tumor, and treatment. It has been known for some time that additional factors also influence outcome. These include histologic grade, lymphatic or vascular invasion, mitotic index, performance status, symptoms, and most recently genetic and biochemical markers. It is the aim of this volume to compile those prognostic factors that have emerged as important determinants of outcome for tumors at various sites. This compilation represents the first phase of a more extensive process to integrate all prognostic factors in cancer to further enhance the prediction of outcome following treatment. Certain issues surround ing the assessment and reporting of prognostic factors are also considered. Importance of Prognostic Factors Prognostic factors in cancer often have an immense influence on outcome, while treatment often has a much weaker effect. For example, the influence of the presence of lymph node involvement on survival of patients with metastatic breast cancer is much greater than the effect of adjuvant treatment with tamoxifen in the same group of patients [5].Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 308 pp. Englisch.